[Form 4] Harrow, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Harrow, Inc. (HROW) filed a Form 4 disclosing a stock option grant to Chief Accounting Officer Randall E. Pollard. On 09/01/2025 Mr. Pollard was granted an option to purchase 30,000 shares of common stock at an exercise price of $39 per share. The option expires on 09/01/2035 and is exercisable according to a vesting schedule: 25% at the one-year anniversary and the remainder vesting in 12 equal quarterly installments, becoming fully vested and exercisable on 09/01/2029. The filing was signed by an attorney-in-fact on 09/09/2025.

Positive

• Alignment with shareholders: the multi-year vesting schedule ties executive compensation to long-term stock performance
• Retention incentive: standard one-year cliff plus quarterly vesting supports executive retention through 2029

Negative

• Potential dilution: exercise of 30,000 options would increase share count if and when exercised
• Limited disclosure: Form 4 does not state board approval details or aggregate plan dilution limits, restricting full governance assessment

Insights

Financial Analyst

TL;DR: Routine executive option grant to CFO; modest near-term dilution risk but aligns compensation with stock performance.

The 30,000-share option grant to the Chief Accounting Officer is typical for senior management long-term incentive plans. The $39 exercise price establishes the economic hurdle for value creation: the company stock must exceed $39 before intrinsic value accrues to the holder. Vesting over four years with a one-year cliff encourages retention. From an investor perspective this is a governance/compensation item rather than an operational development and is unlikely to be material alone.

Corporate Governance Expert

TL;DR: Grant follows standard vesting structure and multi-year horizon, supporting retention and alignment without immediate cash impact.

The ten-year term and staged vesting mirror common market practices for executive equity awards. The filing indicates direct ownership and transparency via Section 16 reporting. Key governance considerations—such as whether the grant was approved by the board or compensation committee and plan-level dilution caps—are not disclosed in this Form 4, so assessment of overall shareholder impact is limited by the document's scope.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Pollard Randall E.

(Last) (First) (Middle)

C/O HARROW, INC.

1A BURTON HILLS BLVD., SUITE 200

(Street)

NASHVILLE TN 37215

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
HARROW, INC. [ HROW ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CHIEF ACCOUNTING OFFICER

3. Date of Earliest Transaction (Month/Day/Year)
09/01/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)(1)	$39	09/01/2025		A		30,000		(1)	09/01/2035	Common Stock	30,000	$0	30,000	D

Explanation of Responses:

1. The shares subject to the option shall vest according to the following schedule: 25% of the shares shall vest at the one-year anniversary of the date of grant, and the remaining shares shall vest over the next three years in 12 equal quarterly installments until fully vested and exercisable on September 1, 2029.

	/s/ Andrew R. Boll as Attorney in Fact for Randall Pollard	09/09/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What security was reported in the HROW Form 4?

The filing reports a Stock Option (right to buy) covering 30,000 shares of common stock.

When was the option grant to Randall E. Pollard dated?

The transaction date is 09/01/2025, with the Form 4 signed on 09/09/2025 by an attorney-in-fact.

What is the exercise price and expiration date of the option?

The exercise price is $39 per share and the option expires on 09/01/2035.

How does the option vest?

Vesting is 25% at the one-year anniversary of the grant, then the remainder vests in 12 equal quarterly installments, fully vesting on 09/01/2029.

How many shares will Mr. Pollard own following the grant?

The Form 4 reports 30,000 shares underlying the option as beneficially owned following the reported transaction.